CREATINE_TENCreatine Supplementation for Athletes with Patellar Tendinopathy
This study assesses the impact of creatine supplementation on pain and tendon thickness in athletes suffering from patellar tendinopathy.
Creatine supplementation
+ Placebo
Wounds and Injuries
Treatment Study
Summary
Study start date: January 1, 2021
Actual date on which the first participant was enrolled.This study focuses on understanding how creatine supplements, when used alongside a specific rehabilitation program, can help athletes dealing with patellar tendinopathy, a condition that affects the tendon below the kneecap. The goal is to see if creatine can reduce pain, improve the tendon’s health, and enhance muscle strength and athletic performance, particularly in jumping. The study targets athletes undergoing rehabilitation, which includes exercises that stretch and strengthen the muscles and tendons, as well as treatments like extracorporeal shock wave therapy. This research is important because it could lead to more effective recovery strategies for athletes, helping them return to their sport more quickly and with a lower risk of re-injury. Participants in the study will take creatine supplements while following a structured rehabilitation program. This program includes exercises that focus on building strength and flexibility, alongside special treatments to stimulate healing. Researchers will assess various outcomes, such as changes in pain levels, tendon health, body composition, muscle strength, and jumping ability. By measuring these factors, the study aims to determine whether creatine can enhance the rehabilitation process, potentially offering a simple yet effective way to boost recovery from tendon injuries in athletes.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.26 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Male
Biological sex of participants that are eligible to enroll.From 18 to 49 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
PlaceboStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location